New non-invasive technologies offer hope for women wishing to preserve fertility, but high costs and lack of public insurance ...

Fibroids don’t mean cancer, infertility or hysterectomy. A leading gynaecologist breaks down the biggest myths women still ...

Good morning, and welcome to the TriSalus Life Sciences KOL event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the TriSalus website ...

About The Study: In this cross-sectional study, uterine fibroid embolization was underutilized with significant disparities across socioeconomic factors. Further efforts are needed to equitably expand ...

UTERINE FIBROIDS ARE COMMON, NON-CANCEROUS GROWTHS THAT DEVELOP IN OR AROUND THE UTERUS. THEY OFTEN DON’T CAUSE ANY SYMPTOMS, BUT WHEN THEY DO, THEY CAN BE DEBILITATING. IN THOSE CASES, WOMEN OFTEN ...

Uterine fibroids are the most common benign tumors in women, affecting up to 70% of white women and over 80% of Black women by menopause. Symptoms can include heavy bleeding, pelvic pain, and ...

Fibroids have plagued our community for far too long. According to a recent study, 40% to 80% of women are most likely to develop fibroids by the time they reach 50 years old, with Black women three ...

The global embolization particles market size is valued at USD 1.19 billion in 2024 and is expected to grow to USD 1.34 billion in 2025. Driven by rising demand for minimally invasive procedures, the ...